Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery

A.B.A. Vonk, M.I. Meesters, J. Schats, J.W.A. Romijn, E.K. Jansen, C. Boer

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)135-139
JournalInteractive cardiovascular and thoracic surgery
Issue number2
Publication statusPublished - 2011

Cite this